We envision transforming clinical trial recruitment from a bottleneck into a competitive advantage. Our approach replaces traditional manual recruitment methods with intelligent systems that identify not only eligible patients, but those with the highest biological probability of treatment response, accelerating trial completion and improving success rates.
Current clinical trial recruitment methods face significant challenges that impact pharmaceutical development timelines and costs. Traditional approaches rely heavily on manual processes and basic keyword matching, which are inadequate for the complexity of modern precision medicine.
Trial enrollment often takes months or years to complete, with approximately 80% of trials failing to meet enrollment timelines.
Current systems often rely on basic keyword matching, leading to high screen failure rates and potentially missing suitable candidates with complex medical histories.
Recruitment delays significantly impact drug development timelines and costs, with each day of delay representing substantial financial impact.
Our approach goes beyond traditional keyword matching to understand the biological rationale behind eligibility criteria. We identify patients whose biological profiles align with trial requirements and therapeutic mechanisms, improving both recruitment efficiency and trial success rates.
Our operational approach is a multi-stage process designed for maximum impact. Each step builds upon the last, creating a cascade of strategic advantage.
Stop burning capital on slow, inefficient recruitment. Use our platform to execute precision strikes, fill your trials faster, reduce screen failures, and get your drugs to market on an accelerated timeline. We are your unfair advantage in clinical development.